日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Anaplerotic nutrient stress drives synergy of angiogenesis inhibitors with therapeutics targeting tumor metabolism

补充营养应激促进血管生成抑制剂与肿瘤代谢靶向疗法的协同作用

Sunada Khadka, Yu-Hsi Lin, Jeffrey Ackroyd, Yi-An Chen, Yanghui Sheng, Wubin Qian, Sheng Guo, Yining Chen, Eliot Behr, Yasaman Barekatain, Nasir Uddin, Kenisha Arthur, Victoria Yan, Wen-Hao Hsu, Qing Chang, Anton Poral, Theresa Tran, Surendra Chaurasia, Dimitra K Georgiou, John M Asara, Floris P Bar

Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of ENO1-Deleted Cancers

用于治疗ENO1缺失癌症的1-羟基-2-氧代哌啶-3-基膦酸酯烯醇化酶抑制剂前药

Yan, Victoria C; Pham, Cong-Dat; Ballato, Elliot S; Yang, Kristine L; Arthur, Kenisha; Khadka, Sunada; Barekatain, Yasaman; Shrestha, Prakriti; Tran, Theresa; Poral, Anton H; Washington, Mykia; Raghavan, Sudhir; Czako, Barbara; Pisaneschi, Federica; Lin, Yu-Hsi; Satani, Nikunj; Hammoudi, Naima; Ackroyd, Jeffrey J; Georgiou, Dimitra K; Millward, Steven W; Muller, Florian L

Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine

原发性人类胶质母细胞瘤中纯合的 MTAP 缺失与甲硫腺苷升高无关

Yasaman Barekatain, Jeffrey J Ackroyd, Victoria C Yan, Sunada Khadka, Lin Wang, Ko-Chien Chen, Anton H Poral, Theresa Tran, Dimitra K Georgiou, Kenisha Arthur, Yu-Hsi Lin, Nikunj Satani, Elliot S Ballato, Eliot I Behr, Ana C deCarvalho, Roel G W Verhaak, John de Groot, Jason T Huse, John M Asara, Ra

Why Great Mitotic Inhibitors Make Poor Cancer Drugs

为什么优秀的细胞分裂抑制剂却不是有效的抗癌药物?

Yan, Victoria C; Butterfield, Hannah E; Poral, Anton H; Yan, Matthew J; Yang, Kristine L; Pham, Cong-Dat; Muller, Florian L

COVD-17. TUMOR TREATING FIELDS FOR GLIOBLASTOMA THERAPY DURING THE COVID-19 PANDEMIC: EXPERT CONSENSUS ON USE AND EXPERIENCE

新冠肺炎疫情期间胶质母细胞瘤治疗中肿瘤电场的应用:专家共识及经验

Sumarsono, Andrew; Lalani, Hussain; Segar, Matthew W; Rao, Shreya; Vaduganathan, Muthiah; Wadhera, Rishi K; Das, Sandeep R; Navar, Ann Marie; Fonarow, Gregg C; Pandey, Ambarish; Mamatjan, Yasin; Zuccato, Jeffrey; Moraes, Fabio; Cabanero, Michael; Shali, Wumairehan; Weiss, Jessica; Tsao, Ming; Aldape, Kenneth; Shepherd, Frances; Zadeh, Gelareh; Sarangi, Sasmit; Zhang, Devin; Dong, Anita; Lok, Edwin; Wong, Eric; Khadka, Sunada; Lin, Yu-Hsi; Ackroyd, Jeffrey; Arthur, Kenisha; Barekatain, Yasaman; Poral, Anton; Tran, Theresa; Georgiou, Dimitra; de Groot, John; Huse, Jason; Asara, John; Muller, Florian; Tosha Gatson, Na; Barnholtz-Sloan, Jill S; Drappatz, Jan; Henriksson, Roger; Hottinger, Andreas; Hinoul, Piet; Kruchko, Carol; Puduvalli, Vinay; Tran, David; Wong, Eric; Glas, Martin

TAMI-62. ANGIOGENESIS INHIBITORS STRONGLY SYNERGIZE WITH THERAPEUTICS TARGETING TUMOR METABOLISM

TAMI-62。血管生成抑制剂与靶向肿瘤代谢的疗法具有显著的协同作用。

Otsu, Satoshi; Hironaka, Shuichi; Khadka, Sunada; Lin, Yu-Hsi; Ackroyd, Jeffrey; Arthur, Kenisha; Barekatain, Yasaman; Poral, Anton; Tran, Theresa; Georgiou, Dimitra; de Groot, John; Huse, Jason; Asara, John; Muller, Florian

Bioreducible Phosphonoamidate Pro-drug Inhibitor of Enolase: Proof of Concept Study

生物可还原膦酰胺前药烯醇化酶抑制剂:概念验证研究

Yan, Victoria C; Yang, Kristine L; Ballato, Elliot S; Khadka, Sunada; Shrestha, Prakriti; Arthur, Kenisha; Georgiou, Dimitra K; Washington, Mykia; Tran, Theresa; Poral, Anton H; Pham, Cong-Dat; Yan, Matthew J; Muller, Florian L